Report Detail

Pharma & Healthcare Global Armodafinil Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3646048
  • |
  • 06 August, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil.

Scope of the Report:
The global Armodafinil market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Armodafinil.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Armodafinil market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Armodafinil market by product type and applications/end industries.

Market Segment by Companies, this report covers
Teva
Mylan
Apotex
Lupin
Sandoz
Natco Pharma
Aurobindo

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
50 mg Tablets
150 mg Tablets
200 mg Tablets
250 mg Tablets

Market Segment by Applications, can be divided into
Obstructive Sleep Apnea (OSA) and Narcolepsy
Shift Work Disorder (SWD)
Patients with Severe Hepatic Impairment
Geriatric Patients


Table of Contents

    1 Armodafinil Market Overview

    • 1.1 Product Overview and Scope of Armodafinil
    • 1.2 Classification of Armodafinil by Types
      • 1.2.1 Global Armodafinil Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Armodafinil Revenue Market Share by Types in 2018
      • 1.2.3 50 mg Tablets
      • 1.2.4 150 mg Tablets
      • 1.2.5 200 mg Tablets
      • 1.2.6 250 mg Tablets
    • 1.3 Global Armodafinil Market by Application
      • 1.3.1 Global Armodafinil Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
      • 1.3.3 Shift Work Disorder (SWD)
      • 1.3.4 Patients with Severe Hepatic Impairment
      • 1.3.5 Geriatric Patients
    • 1.4 Global Armodafinil Market by Regions
      • 1.4.1 Global Armodafinil Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Armodafinil Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Armodafinil Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Armodafinil Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Armodafinil Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Armodafinil Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Armodafinil (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Teva
      • 2.1.1 Business Overview
      • 2.1.2 Armodafinil Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Teva Armodafinil Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Mylan
      • 2.2.1 Business Overview
      • 2.2.2 Armodafinil Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Mylan Armodafinil Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Apotex
      • 2.3.1 Business Overview
      • 2.3.2 Armodafinil Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Apotex Armodafinil Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Lupin
      • 2.4.1 Business Overview
      • 2.4.2 Armodafinil Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Lupin Armodafinil Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Sandoz
      • 2.5.1 Business Overview
      • 2.5.2 Armodafinil Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Sandoz Armodafinil Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Natco Pharma
      • 2.6.1 Business Overview
      • 2.6.2 Armodafinil Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Natco Pharma Armodafinil Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Aurobindo
      • 2.7.1 Business Overview
      • 2.7.2 Armodafinil Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Aurobindo Armodafinil Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Armodafinil Market Competition, by Players

    • 3.1 Global Armodafinil Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Armodafinil Players Market Share
      • 3.2.2 Top 10 Armodafinil Players Market Share
    • 3.3 Market Competition Trend

    4 Global Armodafinil Market Size by Regions

    • 4.1 Global Armodafinil Revenue and Market Share by Regions
    • 4.2 North America Armodafinil Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Armodafinil Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Armodafinil Revenue and Growth Rate (2014-2019)
    • 4.5 South America Armodafinil Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Armodafinil Revenue and Growth Rate (2014-2019)

    5 North America Armodafinil Revenue by Countries

    • 5.1 North America Armodafinil Revenue by Countries (2014-2019)
    • 5.2 USA Armodafinil Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Armodafinil Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Armodafinil Revenue and Growth Rate (2014-2019)

    6 Europe Armodafinil Revenue by Countries

    • 6.1 Europe Armodafinil Revenue by Countries (2014-2019)
    • 6.2 Germany Armodafinil Revenue and Growth Rate (2014-2019)
    • 6.3 UK Armodafinil Revenue and Growth Rate (2014-2019)
    • 6.4 France Armodafinil Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Armodafinil Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Armodafinil Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Armodafinil Revenue by Countries

    • 7.1 Asia-Pacific Armodafinil Revenue by Countries (2014-2019)
    • 7.2 China Armodafinil Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Armodafinil Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Armodafinil Revenue and Growth Rate (2014-2019)
    • 7.5 India Armodafinil Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Armodafinil Revenue and Growth Rate (2014-2019)

    8 South America Armodafinil Revenue by Countries

    • 8.1 South America Armodafinil Revenue by Countries (2014-2019)
    • 8.2 Brazil Armodafinil Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Armodafinil Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Armodafinil Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Armodafinil by Countries

    • 9.1 Middle East and Africa Armodafinil Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Armodafinil Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Armodafinil Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Armodafinil Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Armodafinil Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Armodafinil Revenue and Growth Rate (2014-2019)

    10 Global Armodafinil Market Segment by Type

    • 10.1 Global Armodafinil Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Armodafinil Market Forecast by Type (2019-2024)
    • 10.3 50 mg Tablets Revenue Growth Rate (2014-2024)
    • 10.4 150 mg Tablets Revenue Growth Rate (2014-2024)
    • 10.5 200 mg Tablets Revenue Growth Rate (2014-2024)
    • 10.6 250 mg Tablets Revenue Growth Rate (2014-2024)

    11 Global Armodafinil Market Segment by Application

    • 11.1 Global Armodafinil Revenue Market Share by Application (2014-2019)
    • 11.2 Armodafinil Market Forecast by Application (2019-2024)
    • 11.3 Obstructive Sleep Apnea (OSA) and Narcolepsy Revenue Growth (2014-2019)
    • 11.4 Shift Work Disorder (SWD) Revenue Growth (2014-2019)
    • 11.5 Patients with Severe Hepatic Impairment Revenue Growth (2014-2019)
    • 11.6 Geriatric Patients Revenue Growth (2014-2019)

    12 Global Armodafinil Market Size Forecast (2019-2024)

    • 12.1 Global Armodafinil Market Size Forecast (2019-2024)
    • 12.2 Global Armodafinil Market Forecast by Regions (2019-2024)
    • 12.3 North America Armodafinil Revenue Market Forecast (2019-2024)
    • 12.4 Europe Armodafinil Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Armodafinil Revenue Market Forecast (2019-2024)
    • 12.6 South America Armodafinil Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Armodafinil Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Armodafinil. Industry analysis & Market Report on Armodafinil is a syndicated market report, published as Global Armodafinil Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Armodafinil market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,690.04
      4,035.06
      5,380.08
      3,239.88
      4,859.82
      6,479.76
      531,361.20
      797,041.80
      1,062,722.40
      293,712.00
      440,568.00
      587,424.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report